Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

Completed

• Conditions: Lung Cancer

• Registration Number: NCT00185913
• Lead Sponsor: Stanford University

Brief Summary

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-09
• Primary Completion: 2003-10
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-16
• Study Completion: 2008-05
• Status Verified: 2010-04
• Last Update Submitted: 2010-04-20
• Last Update Posted: 2010-04-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors

Exclusion Criteria

• Patients without non-small cell lung cancer

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Stanford University School of Medicine; 🇺🇸 Stanford, California, United States